120 related articles for article (PubMed ID: 4330605)
1. Bone collagenase in assessment of the clinical course of metabolic bone disease.
Gardner B; Wallach S; Gray H; Baker RK
Surg Forum; 1971; 22():435-7. PubMed ID: 4330605
[No Abstract] [Full Text] [Related]
2. Bone collagenase in osteolytic stress of rats and humans.
Gardner B; Gray H; Hedayati H
Surg Forum; 1970; 21():467-8. PubMed ID: 4328384
[No Abstract] [Full Text] [Related]
3. [Hydrolytic enzymes in bone].
Goseki M; Oida S; Sasaki S
Nihon Rinsho; 1990 Dec; 48(12):2828-32. PubMed ID: 1964971
[No Abstract] [Full Text] [Related]
4. Kinetic and metabolic investigations in Paget's disease of bone, assessment of human synthetic calcitonin therapy.
Reiner M; Woodhouse NJ; Kalu DN; Foster GV; Galante L; Joplin GF; MacIntyre I
Helv Med Acta Suppl; 1970 Jun; ():Suppl 50:136. PubMed ID: 5288785
[No Abstract] [Full Text] [Related]
5. Osteogenesis imperfecta and Paget's disease of bone. Biochemical and morphologic studies.
Shapiro JR; Triche T; Rowe DW; Munabi A; Cattell HS; Schlesinger S
Arch Intern Med; 1983 Dec; 143(12):2250-7. PubMed ID: 6651417
[TBL] [Abstract][Full Text] [Related]
6. [Peri-osteocytic calcium fixation under calcitonin treatment. Microradiographic study using automatic analysis of images in 8 cases of osteogenesis imperfecta].
Duriez J; Flautre B
Nouv Presse Med; 1975 Jan; 04(2):97-100. PubMed ID: 1138231
[TBL] [Abstract][Full Text] [Related]
7. A clinical appraisal of calcitonin.
Boyle IT
Scott Med J; 1970 Jun; 15(6):203-6. PubMed ID: 5427157
[No Abstract] [Full Text] [Related]
8. The pharmacology of bone.
Raisz LG
Ration Drug Ther; 1971 Jun; 5(6):1-7. PubMed ID: 5565260
[No Abstract] [Full Text] [Related]
9. Direct extraction and assay of bone tissue collagenase and its relation to parathyroid-hormone-induced bone resorption.
Eeckhout Y; Delaissé JM; Vaes G
Biochem J; 1986 Nov; 239(3):793-6. PubMed ID: 3030273
[TBL] [Abstract][Full Text] [Related]
10. Histological effects of calcitonin in bone diseases.
Olah AJ; Dambacher M; Haas HG
Calcif Tissue Res; 1970; ():Suppl:154. PubMed ID: 5427964
[No Abstract] [Full Text] [Related]
11. Calcitonin and metabolic bone disease.
Lancet; 1971 Jun; 1(7710):1168-9. PubMed ID: 4102868
[No Abstract] [Full Text] [Related]
12. The cellular basis of metabolic bone disease.
Rasmussen H; Bordier P
N Engl J Med; 1973 Jul; 289(1):25-32. PubMed ID: 4575395
[No Abstract] [Full Text] [Related]
13. [Biochemical markers of bone turnover. New aspect. Metabolic bone markers in osteogenesis imperfecta].
Tanaka H
Clin Calcium; 2009 Aug; 19(8):1142-7. PubMed ID: 19638698
[TBL] [Abstract][Full Text] [Related]
14. Immunoreactive collagenase and bone resorption.
Francois-Gillet C; Delaissé JM; Eeckhout Y; Vaes G
Biochim Biophys Acta; 1981 Feb; 673(1):1-9. PubMed ID: 6258650
[TBL] [Abstract][Full Text] [Related]
15. [Clinical and therapeutic studies of synthetic salmon calcitonin in some osteopathies].
Torrioli E; Citti C; Picchi L
Clin Ter; 1982 Jul; 102(2):123-9. PubMed ID: 6183044
[No Abstract] [Full Text] [Related]
16. Fluoride therapy in metabolic bone disease.
Spencer H; Kramer L; Wiatrowski E; Lender M
Isr J Med Sci; 1984 May; 20(5):373-80. PubMed ID: 6469556
[TBL] [Abstract][Full Text] [Related]
17. Clinical studies of bone metabolism using a simple model of calcium tracer kinetics.
Roncari G
Nuklearmedizin; 1981 Aug; 20(4):183-6. PubMed ID: 7024923
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology and therapeutics of bone.
Sturtridge WC
J Dent Res; 1975 Jun; 54 Spec No B():B78-85. PubMed ID: 166098
[No Abstract] [Full Text] [Related]
19. Recent advances in the unerstanding and management of metabolic bone disease.
Smith R
Proc R Soc Med; 1970 Sep; 63(9):931-4. PubMed ID: 4921479
[No Abstract] [Full Text] [Related]
20. [Disorder of bone quality in Paget's disease].
Tsurukami H
Clin Calcium; 2005 Jun; 15(6):1000-6. PubMed ID: 15930714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
